CPT code 0267U: Genome test, mapping plus sequencing2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Optical genome mapping combined with whole-genome sequencing detects structural genomic variants associated with rare constitutional and other heritable disorders.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide

Medicare pays $6,739.33 for 0267U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$6,739.33

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2023
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 7 sections
  1. Medicare lab fee
  2. What 0267U covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Billing questions
  7. Sources

What 0267U covers

0267U identifies a proprietary laboratory assay that combines optical genome mapping with whole-genome sequencing to evaluate rare constitutional and other heritable disorders. The methods detect structural genomic variants, including copy-number variations, inversions, insertions, translocations, and other structural changes. The code identifies this combined approach to rare-disease testing.

Report 0267U for this combined laboratory service. Medicare pays the code under the CLFS using one national amount that applies across states and localities, without geographic or office-versus-facility adjustment. The 2026 national CLFS amount is $6,739.33, unchanged from 2023 through 2026. Payment is through the CLFS only.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 0267U

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 0267U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Not on the physician fee schedule

The physician fee schedule doesn’t list 0267U: Medicare pays the test only from the CLFS.

0267U on the lab fee schedule since 2021

0267U · CLFS 2026 Q4 (current)

$6,739.33

Unchanged since Jan 1, 2023

Amount in each year’s latest CLFS release · bars start at $0

Every change on file

  1. Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $6,739.33

21 quarterly CLFS releases on file, first CLFS 2021 Q4. A code missing from a quarter wasn’t on that release.

0267U compared with similar tests

0260UGenome mappingStructural variant detection$1,263.53
0260U is identified as a rare-disease optical genome-mapping test. 0267U identifies a test combining optical genome mapping with whole-genome sequencing.
0264UGenome mappingStructural variant detection$1,263.53
0264U is identified as a rare-disease optical genome-mapping test. 0267U identifies a test combining optical genome mapping with whole-genome sequencing.
0265UGenome sequencingRare heritable disorders$5,475.80
0265U is identified as rare-disease whole-genome and mitochondrial DNA analysis; 0267U combines optical genome mapping with whole-genome sequencing.

0267U billing questions

What does 0267U evaluate?

It combines optical genome mapping and whole-genome sequencing to detect structural genomic variants associated with rare constitutional and other heritable disorders.

Which structural variants are included?

The assay detects copy-number variations, inversions, insertions, translocations, and other structural variants.

How does 0267U differ from 0260U or 0264U?

Those codes are identified as rare-disease optical genome-mapping tests. 0267U identifies a test combining optical genome mapping with whole-genome sequencing; select the code that matches the assay performed.

How does Medicare pay for 0267U?

Medicare pays 0267U under the CLFS at one national amount across localities and practice settings.

Is there a separate physician fee schedule payment?

Medicare pays 0267U through the CLFS only.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 0267UPUF_CLFS_CY2026_Q4V1.csv, line 237 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 0267U?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 0267U and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist